ストックスクリーナーアプリを入手
21.97
0.88%
0.1926
アフターアワーズ：
21.99
0.02
+0.09%
前日終値:
$21.78
開ける：
$21.94
24時間の取引高:
17,853
Relative Volume:
0.52
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-2.57%
1か月 パフォーマンス:
-1.70%
6か月 パフォーマンス:
-9.63%
1年 パフォーマンス:
-9.10%
1日の値動き範囲:
$21.75
$22.06
1週間の範囲:
$21.48
$22.71
52週間の値動き範囲:
$21.48
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
IDNA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
21.97 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
275.04 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
558.87 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
561.48 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
221.94 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
476.92 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf (IDNA) 最新ニュース
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Moderna, Pfizer Surge Amid CDC-WHO Split And Bird Flu; RFK Jr. Nomination Looms — A Recipe For The Perfect Storm? - Benzinga
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
Future Health: Harnessing Innovations In Healthcare - Syfe
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for February 2025 - Wealth Awesome
BlackRock® Canada Announces June Cash Distributions for the iShares® ETFs - Yahoo Finance
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Canada Finance
Has Biotechnology Bottomed Out? - Master Investor
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing | Investing | U.S. News - U.S News & World Report Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - Yahoo Finance
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher - InvestorPlace
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
RBC iShares Opens the Market - Canada NewsWire
ETF Battles: ARKG Vs IDNA Vs GNOM - Yahoo Finance
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
Go Beyond Trends: Healthcare Megatrends and IDNA - ETFdb.com
Genomics ETFs Surge on CRISPR's Gene Editing Progress - Zacks Investment Research
Why megatrend ETFs offer long-term growth potential - ETF Strategy
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Launches Megatrend ETF Suite Designed to Capture Five Transformational Long-Term Trends - Business Wire
BlackRock lists genomics and cyber security ETFs - ETF Stream
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
ARK Genomic Revolution ETF - ETFdb.com
Ishares Genomics Immunology And Healthcare Etf (IDNA) 財務データ
Ishares Genomics Immunology And Healthcare Etf (IDNA) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.45%
1.37%
大文字化:
|
ボリューム (24 時間):